Genomic and experimental evidence that ALK(ATI) does not predict single agent sensitivity to ALK inhibitors

Genomic data can facilitate personalized treatment decisions by enabling therapeutic hypotheses in individual patients. Mutual exclusivity has been an empirically useful signal for identifying activating mutations that respond to single agent targeted therapies. However, a low mutation frequency can...

Descripción completa

Detalles Bibliográficos
Autores principales: Inam, Haider, Sokirniy, Ivan, Rao, Yiyun, Shah, Anushka, Naeemikia, Farnaz, O'Brien, Edward, Dong, Cheng, McCandlish, David M., Pritchard, Justin R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603052/
https://www.ncbi.nlm.nih.gov/pubmed/34825133
http://dx.doi.org/10.1016/j.isci.2021.103343

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603052/
https://www.ncbi.nlm.nih.gov/pubmed/34825133
http://dx.doi.org/10.1016/j.isci.2021.103343

Ejemplares similares